JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arao, T.
Right arrow Articles by Kubota, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arao, T.
Right arrow Articles by Kubota, I.
Journal of Nuclear Medicine Vol. 44 No. 11 1747-1754
© 2003 by Society of Nuclear Medicine


Clinical Investigations

In Vivo Evidence of Endothelial Injury in Chronic Obstructive Pulmonary Disease by Lung Scintigraphic Assessment of 123I-Metaiodobenzylguanidine

Tsuyoshi Arao, MD1, Noriaki Takabatake, MD1, Makoto Sata, MD1, Shuichi Abe, MD1, Yoko Shibata, MD2, Tsuguo Honma, MD3, Kazuei Takahashi3, Akio Okada3, Yasuchika Takeishi, MD1 and Isao Kubota, MD1

1 First Department of Internal Medicine, Yamagata University School of Medicine, Yamagata, Japan
2 Department of Laboratory Medicine, Yamagata University School of Medicine, Yamagata, Japan
3 Department of Radiology, Yamagata University School of Medicine, Yamagata, Japan

Scintigraphic evaluation of 123I-metaiodobenzylguanidine (123I-MIBG) in the lungs is considered to recognize endothelial cell lesions. The aim of this study was to clarify the involvement of the pulmonary microvascular injury in the pathogenesis of chronic obstructive pulmonary disease (COPD). Methods: We investigated lung 123I-MIBG kinetics and clinical indices in 25 COPD patients and 12 control subjects. Mean uptake ratios of lung to mediastinum (L/M) were calculated in anterior planer images at 30 min (early image) and 270 min (delayed image) after intravenous injection of 123I-MIBG. Pulmonary mean washout rate (WR) of the 123I-MIBG was also calculated. Results: The L/M ratios in both early and delayed images of COPD patients, as well as its WR, were significantly lower than those of the control subjects (L/M early: 1.26 ± 0.18 vs. 1.54 ± 0.11, P < 0.0001; L/M delayed: 1.20 ± 0.12 vs. 1.33 ± 0.09, P < 0.001; WR: 27.4% ± 5.3% vs. 34.2% ± 5.7%, P < 0.01). There were significant relationships between lung WR of the 123I-MIBG and other diagnostic tests for the severity of COPD, such as forced expiratory volume in 1 s (% FEV1.0: r = 0.386, P < 0.05), carbon monoxide diffusing capacity/alveolar volume (DLCO/VA: r = 0.449, P < 0.01), arterial blood oxygen pressure (PaO2: r = 0.474, P < 0.01), alveolar–arterial oxygen tension gradient [A–a]DO2 (r = -0.446, P < 0.01), and percentage of low-attenuation area (r = -0.458, P < 0.01) in the study population. Conclusion: Because lung WR of the 123I-MIBG is considered to be independent of an alteration of the pulmonary vascular surface area, these results suggest that the microvascular endothelial cell injury plays a significant role in the pathogenesis of COPD.

Key Words: chronic obstructive pulmonary disease • 123I-metaiodobenzylguanidine • microvascular endothelial cell injury




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
N. Takabatake, Y. Shibata, S. Abe, T. Wada, J.-i. Machiya, A. Igarashi, Y. Tokairin, G. Ji, H. Sato, M. Sata, et al.
A Single Nucleotide Polymorphism in the CCL1 Gene Predicts Acute Exacerbations in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 875 - 885.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K.-H. Lee, B.-H. Ko, J.-Y. Paik, K.-H. Jung, J.-S. Bae, J.-Y. Choi, Y. S. Choe, and B.-T. Kim
Characteristics and Regulation of 123I-MIBG Transport in Cultured Pulmonary Endothelial Cells
J. Nucl. Med., March 1, 2006; 47(3): 437 - 442.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.